What question did this study set out to answer?

The study aims to examine the role of IL-17 levels in assessing disease activity in spondyloarthritis and its relationship with various treatments.

April 22, 2026Tanta Medical JournalOpen Access

Role of interleukin-17 level in assessment of disease activity in peripheral and axial spondyloarthritis and its relation to different methods of treatment

View Full Paper

Ask AI

Bookmark

Authors

Case-control study investigates IL-17 levels and treatment effects on disease activity in spondyloarthritis, suggesting treatment implications.

The study aims to examine the role of IL-17 levels in assessing disease activity in spondyloarthritis and its relationship with various treatments.
Conducted a case-control study with 40 participants divided into axial, peripheral, and both types of spondyloarthritis.
Participants received comprehensive clinical assessments and laboratory tests for IL-17 and C-reactive protein.
Analysis included disease activity measurements using established scales.
IL-17 levels were significantly higher in spondyloarthritis patients compared to healthy controls (P < 0.05).
Significant reduction in IL-17 and other disease activity scores was observed in peripheral spondyloarthritis compared to axial cases.
Treatment response differed, favoring biologic disease-modifying antirheumatic drugs in peripheral spondyloarthritis.

Abdelwahab et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Case-control study investigates IL-17 levels and treatment effects on disease activity in spondyloarthritis, suggesting treatment implications.